Aprogen Biologics Inc.
Research Aprogen Biologics Inc. (003060.KS) on Bullrun: market cap KRW 24.60B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker003060.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 24.60B
- Financial periodQ2 2026
- RevenueKRW 23.08B
- Net income-KRW 13.98B
- Free cash flow-KRW 7.29B
- Gross margin-41.2%
Valuation Snapshot
latest market cap is KRW 24.60B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 24.60B | n/a | n/a | n/a |
Dividend history
About Aprogen Biologics Inc.
Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea. The company was founded in 1960 and is headquartered in Seoul, South Korea.
ETFs that hold Aprogen Biologics Inc.
US-listed ETFs
Aprogen Biologics Inc. is held by 2 US-listed ETFs, going by the latest portfolios they filed with the SEC, most traded first:
| ETF | Weight | Fee |
|---|---|---|
| Avantis Emerging Markets Equity ETF (AVEM) | <0.01% | 0.33% |
| Avantis Emerging Markets Small Cap Equity ETF (AVEE) | <0.01% | 0.42% |
Portfolios as filed with the SEC on Form N-PORT, dated May 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Aprogen Biologics Inc.'s market cap?
Aprogen Biologics Inc.'s market capitalization is KRW 24.60B.
What does Aprogen Biologics Inc. do?
Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea. The company was founded in 1960 and is headquartered in Seoul, South Korea.